Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Oncogene

• Publication date

  1994-07-31

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8036014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA.

  1994cited by this paper
• Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells.

  1994cited by this paper
• Calcium-binding properties of osteopontin derived from non-osteogenic sources.

  1993cited by this paper
• 1 alpha,25-Dihydroxyvitamin D3 enhances 12-O-tetradecanoylphorbol-13-acetate- induced tumorigenic transformation and osteopontin expression in mouse JB6 epidermal cells.

  1993cited by this paper
• Developmental expression of osteopontin (OPN) mRNA in rat tissues: evidence for a role for OPN in bone formation and resorption.

  1993cited by this paper
• Structure and expression of the mRNA encoding urinary stone protein (osteopontin).

  1993cited by this paper
• Osteopontin: a protein with diverse functions

  1993cited by this paper
• Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption.

  1993cited by this paper
• Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.

  1992cited by this paper
• Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone.

  1992cited by this paper
• Role of the alpha v beta 3 integrin in human melanoma cell invasion.

  1992cited by this paper
• Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces.

  1992cited by this paper
• Integrins: versatility, modulation, and signaling in cell adhesion.

  1992cited by this paper
• Involvement of integrin alpha V gene expression in human melanoma tumorigenicity.

  1992cited by this paper
• Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts.

  1991cited by this paper
• Cell adhesion receptor expression during melanoma progression and metastasis

  1991cited by this paper
• Stromelysin in tumor progression and metastasis

  1990cited by this paper
• Osteopontin--a possible anchor of osteoclasts to bone.

  1990cited by this paper
• Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression.

  1990cited by this paper
• A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo.

  1989cited by this paper
• Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation.

  1989cited by this paper
• Cell attachment activity of the 44 kilodalton bone phosphoprotein is not restricted to bone cells.

  1989cited by this paper
• Changes in integrin receptors on oncogenically transformed cells.

  1989cited by this paper
• Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization

  1988cited by this paper
• Identification of the major phosphoprotein secreted by many rodent cell lines as 2ar/osteopontin: enhanced expression in H-ras-transformed 3T3 cells.

  1988cited by this paper
• Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation.

  1988cited by this paper
• The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors.

  1986cited by this paper
• Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence.

  1986cited by this paper
• Bacterial beta-galactosidase as a marker of Rous sarcoma virus gene expression and replication

  1985cited by this paper
• Secreted phosphoprotein markers for neoplastic transformation of human epithelial and fibroblastic cells.

  1985cited by this paper
• A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells

  1983cited by this paper
• Transformation-specific secreted phosphoproteins

  1980cited by this paper

• Genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer

  2024cites this paper
• Regulatory Roles of Osteopontin in Production of Monocyte-Origin MCP-1

  2018cites this paper
• Mapping the genetic basis of breast microcalcifications and their role in metastasis

  2018cites this paper
• Integrative Analysis of Transcriptome and MicroRNome Profiles inCholangiocarcinoma

  2017cites this paper
• Role of osteopontin in lung cancer evolution and heterogeneity.

  2017cites this paper
• The Role of nAChR and Calcium Signaling in Pancreatic Cancer Initiation and Progression

  2015cites this paper
• Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.

  2015cites this paper
• Overexpressed ostepontin-c as a potential biomarker for esophageal squamous cell carcinoma.

  2013cites this paper
• Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor

  2012cites this paper
• Osteopontin increases the proliferation of neural progenitor cells

  2012cites this paper
• Serum osteopontin and CD44 levels in lymphoreticular malignancies in children.

  2012cites this paper
• The neuroprotective role of osteopontin in in-vitro and in-vivo models of Parkinson's disease

  2012cites this paper
• The metastasis-associated extracellular matrix protein osteopontin forms transient structure in ligand interaction sites.

  2011cites this paper
• Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.

  2010cites this paper
• Inhibitory effect of short hairpin RNA expression vector mediated osteopontin RNA interference on proliferation and invasion of prostate cancer PC 3 cells

  2010cites this paper
• Expression and function of osteopontin variants in HCV-related liver disease and hepatocellular carcinoma.

  2010cites this paper
• Functional Heterogeneity of Osteopontin Isoforms in Non-small Cell Lung Cancer

  2010cites this paper
• Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity.

  2010cites this paper
• Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells

  2009cites this paper
• Comprehensive study on the prognostic role of osteopontin expression in oral squamous cell carcinoma.

  2009cites this paper
• Role of osteopontin in cellular signaling and metastatic phenotype.

  2008cites this paper
• Osteopontina como marcador de resposta à radioterapia e quimioterapia em pacientes com câncer de cabeça e pescoço localmente avançado

  2008cites this paper
• Osteopontin: regulation in tumor metastasis

  2008cites this paper
• Corneal wound healing in an osteopontin-deficient mouse.

  2008cites this paper
• Osteopontin: an emerging therapeutic target for anticancer therapy

  2007cites this paper
• Collagen Gels

  2007cites this paper
• The inhibition of in vivo tumorigenesis of osteosarcoma (OS)-732 cells by antisense human osteopontin RNA

  2007cites this paper
• Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain.

  2007cites this paper
• Loss of osteopontin perturbs the epithelial-mesenchymal transition in an injured mouse lens epithelium

  2007cites this paper
• Effects of polyphenols derived from fruit of Crataegus pinnatifida on cell transformation, dermal edema and skin tumor formation by phorbol ester application.

  2007cites this paper
• Osteopontin Knockdown Suppresses Tumorigenicity of Human Metastatic Breast Carcinoma, MDA-MB-435

  2006cites this paper
• Osteopontin: role in cell signaling and cancer progression.

  2006cites this paper
• A Molecular Connection Between Cancer Proliferation and Metastasis Mediated by Akt Kinase

  2006cites this paper
• Nuclear factor inducing kinase: A key regulator in osteopontin- induced MAPK/IκB kinase dependent NF-κB-mediated promatrix metalloproteinase-9 activation

  2006cites this paper
• Identification of apolipoprotein D as a novel inhibitor of osteopontin-induced neoplastic transformation.

  2006cites this paper
• Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.

  2006cites this paper
• The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis.

  2006cites this paper
• Elevated Plasma Osteopontin Levels in Patients with Hepatocellular Carcinoma

  2006cites this paper
• Inhibition of osteopontin expression and function in oral cancer cell lines by antisense oligonucleotides.

  2005cites this paper
• Autocrine secretion of osteopontin results in degradation of I kappa B in Bcr-Abl-expressing cells.

  2005cites this paper
• Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non–Small Cell Lung Cancer

  2005cites this paper
• Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry.

  2005cites this paper
• Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma.

  2005cites this paper
• Nitric Oxide-Dependent Osteopontin Expression Induces Metastatic Behavior in HepG2 Cells

  2005cites this paper
• Autocrine secretion of osteopontin results in degradation of IκB in Bcr‐Abl‐expressing cells

  2005cites this paper
• Osteopontin expression correlates with melanoma invasion.

  2005cites this paper
• Contribution of Osteopontin to the Development of Bone Metastasis

  2005cites this paper
• The role of Osteopontin in tumor metastasis.

  2004cites this paper
• Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells

  2004cites this paper
• Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine

  2004cites this paper
• The Role of Osteopontin in Vascular Remodeling

  2004cites this paper
• Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin

  2004cites this paper
• Osteopontin expression correlates with adhesive and metastatic potential in metastasis-inducing DNA-transfected rat mammary cell lines

  2004cites this paper
• Matrix metalloproteinase-2: Mechanism and regulation of NF-κB-mediated activation and its role in cell motility and ECM-invasion

  2004cites this paper
• RESEARCH REVIEW The Role of Osteopontin in Tumor Metastasis

  2004cites this paper
• Osteopontin But Not Osteonectin Messenger RNA Expression Is a Prognostic Marker in Curatively Resected Non-Small Cell Lung Cancer

  2004cites this paper
• Osteopontin, a Surprisingly Flexible Cytokine

  2003cites this paper
• Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells.

  2003cites this paper
• Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.

  2003cites this paper
• Proliferation in Vivo Signal-regulated Kinase Activation , and Increased Osteopontin Induction , Extracellular ( FGFR ) 1 , but not FGFR 2 , in Prostate Cancer Cells Leads to Conditional Activation of Fibroblast Growth Factor Receptor

  2003cites this paper
• Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma

  2003cites this paper
• Osteopontin contributes to hepatocyte growth factor-induced tumor growth and metastasis formation.

  2003cites this paper
• Oncogene-Directed Therapies

  2003influential citation
• Oncogenes as Therapeutic Targets to Prevent Metastasis

  2003cites this paper
• Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status

  2003cites this paper
• Osteopontin--a molecule for all seasons.

  2002cites this paper
• Osteopontin: A Ras-Regulated Gene That Contributes to Tumor Metastasis

  2002cites this paper
• Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.

  2002cites this paper
• Metastasis-inducing dna regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4.

  2002cites this paper
• Identification of the Osteopontin gene as a direct target of TP53

  2002cites this paper
• PEA3 Subfamily Transcriptional Activation of Osteopontin, A Transformation-Associated Protein

  2001cites this paper
• The Osteopontin-CD44 Survival Signal Involves Activation of the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway*

  2001cites this paper
• The metastasis gene osteopontin: a candidate target for cancer therapy.

  2001cites this paper
• Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.

  2001cites this paper
• Osteopontin Stimulates Tumor Growth and Activation of Promatrix Metalloproteinase-2 through Nuclear Factor-κB-mediated Induction of Membrane Type 1 Matrix Metalloproteinase in Murine Melanoma Cells*

  2001cites this paper
• Role of osteopontin in cellular signaling and toxicant injury.

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• Osteopontin Activation of C-WC in Human Melanoma Cells Requires the Cytoplasmic Domain of the Integrin %-Subunit

  2001cites this paper
• Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line

  2001cites this paper
• Coupling of Osteopontin and Its Cell Surface Receptor CD44 to the Cell Survival Response Elicited by Interleukin-3 or Granulocyte-Macrophage Colony-Stimulating Factor

  2000cites this paper
• Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK.

  2000cites this paper
• Mammary tumor development in MMTV-c-myc/MMTV-v-Ha-ras transgenic mice is unaffected by osteopontin deficiency

  2000cites this paper
• Osteopontin is required for full expression of the transformed phenotype by the ras oncogene

  2000cites this paper
• Osteopontin Function in Pathology: Lessons from Osteopontin-Deficient Mice

  1999cites this paper
• Loss of transformed phenotype in cancer cells by overexpression of the uteroglobin gene.

  1999cites this paper
• Functions of the extracellular matrix and matrix degrading proteases during tumor progression.

  1999cites this paper
• Redox regulation of c-Ha-ras and osteopontin signaling in vascular smooth muscle cells: implications in chemical atherogenesis.

  1999cites this paper
• Mice Lacking Osteopontin Show Normal Development and Bone Structure but Display Altered Osteoclast Formation In Vitro

  1998cites this paper
• Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo.

  1998cites this paper
• Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue.

  1998cites this paper
• Coordinate expression of OPN and associated receptors during monocyte/macrophage differentiation of HL‐60 cells

  1998cites this paper
• Osteopontin.

  1998cites this paper
• Generation of metastatic variants by transfection of a rat non-metastatic epithelial cell line with genomic DNA from rat prostatic carcinoma cells.

  1998cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  1998cites this paper
• Altered sialylation of osteopontin prevents its receptor-mediated binding on the surface of oncogenically transformed tsB77 cells.

  1997cites this paper
• Angiogenesis and Metastasis

  1997cites this paper
• The role of osteopontin in tumorigenesis and metastasis.

  1997cites this paper
• Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways

  1997cites this paper
• Differential processing of osteopontin characterizes the proliferative vascular smooth muscle cell phenotype induced by allylamine

  1997cites this paper
• Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line

  1997cites this paper